BioTime Inc. (BTX)
Symbol Info
Listed Symbol BTX
Name BioTime Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $4,988,000
Latest Fiscal EPS $-0.35
Price Info
21 Day Moving Average $1.1033
21 Day EMA $1.069430
50 Day Moving Average $1.0762
50 Day EMA $1.100070
200 Day EMA $1.360050
200 Day Moving Average 1.279080
52 Week High $2.81
52 Week Low $0.66
52 Week Change $-60.177498
Alpha -0.023802
Beta 2.7695
Standard Deviation 0.170432
R2 0.314957
Periods 60
Share Information
10 Day Average Volume 491,027
20 Day Average Volume 419,844
30 Day Average Volume 489,565
50 Day Average Volume 441,678
Outstanding Shares 149,642,861
Float Shares 135,364,204
Percent Float 90.46%
Short Interest 9,566,536
Short Percent Float 6.40%
Short Interest Ratio 20.93
Short Date 2019-07-15
Holders
Institutions 201
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 6,476,149
Institute Holdings Percent 52.800000
Institute Sold Previous 3 Months 3,080,315
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months 7
Insider Holdings Percent 9.50%
Insider Sold Previous 3 Months -
Insiders Shares Owned 14,278,657
Price Change
7 Day Price Change $-0.05
7 Day Percent Change -11.55%
21 Day Price Change $-0.11
21 Day Percent Change -16.37%
30 Day Price Change $-0.16
30 Day Percent Change -20.01%
Month To Date Price Change $-0.11
Month To Date Percent -16.37%
90 Day Price Change $-0.19
90 Day Percent Change -22.04%
Quarter To Date $-0.11
Quarter To Date Percent -16.37%
180 Day Price Change $-0.12
180 Day Percent Change -17.13%
200 Day Price Change $-0.0098
200 Day Percent Change -7.99%
Year To Date $0.077000
Year To Date Percent 0.76%
Profile
Description BioTime Inc focuses on regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Details
Issue Type CS
Market Cap $137,656,468
Sec Type EQS
Auditor OUM & Co. LLP
Total Shares Outstanding 149,642,861
CEO Brian M. Culley
Employees 79
Last Audit UE
Classification
CIK 0000876343
Industry Biotechnology
Sector Healthcare
NAICS Biological Product (except Diagnostic) Manufacturing(325414)
Info
Address 1010 Atlantic Avenue
Suite 102
Alameda, CA 94501
Website http://www.biotime.com
Facisimile
Telephone +1 510 521-3390
Email ir@biotimeinc.com
Key Ratios
Profitability
EBIT Margin -812.4
EBITDA Margin -751.5
Pre-Tax Profit Margin -634
Profit Margin Cont -
Gross Margin 95.00
Profit Margin TOT -
Income Statements
Revenue $2,669,000
Revenue Per Share $0.0178
Revenue 3 Years $-16.49
Revenue 5 Years $-6.16
Valuation Measures
PE Ratio 2.20
Enterprise Value $122,125,432
Price To Sales 55.506344
Price To Free Cash -4.7
PE High Last 5 Years -
Price To Book 0.9
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 1.5
Financial Strength
Total Debt To Equity 0.0
Int Coverage -
Current Ratio 3.5
Leverage Ratio 1.1
Quick Ratio 3.3
Long Term Debt To Capital -
Assets
Receivables Turnover 0.4
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets 38.67
Return On Equity 43.28
Return On Capital 43.02
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
AMEX
BTX
BioTime
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.